Survivorship Care for People Affected by Advanced or Metastatic Cancer: MASCC-ASCO Standards and Practice Recommendations

Nicolas H Hart; Larissa Nekhlyudov; Thomas J Smith; Jasmine Yee; Margaret I Fitch; Gregory B Crawford; Bogda Koczwara; Fredrick D Ashbury; Maryam B Lustberg; Michelle Mollica; Andrea L Smith; Michael Jefford; Fumiko Chino; Robin Zon; Meera R Agar; Raymond J Chan

doi:10.1200/OP.23.00716

Survivorship Care for People Affected by Advanced or Metastatic Cancer: MASCC-ASCO Standards and Practice Recommendations

JCO Oncol Pract. 2024 Apr 29:OP2300716. doi: 10.1200/OP.23.00716. Online ahead of print.

Authors

Nicolas H Hart^{1

2

3

4

5}, Larissa Nekhlyudov⁶, Thomas J Smith⁷, Jasmine Yee⁸, Margaret I Fitch⁹, Gregory B Crawford^{10

11}, Bogda Koczwara^{12

13}, Fredrick D Ashbury^{14

15}, Maryam B Lustberg^{16

17}, Michelle Mollica¹⁸, Andrea L Smith¹⁹, Michael Jefford^{20

21}, Fumiko Chino²², Robin Zon^{23

24}, Meera R Agar²⁵, Raymond J Chan^{2

4}

Affiliations

¹ Human Performance Research Centre, INSIGHT Research Institute, Faculty of Health, University of Technology Sydney (UTS), Sydney, NSW, Australia.
² Caring Futures Institute, College of Nursing and Health Science, Flinders University, Adelaide, SA, Australia.
³ Exercise Medicine Research Institute, School of Medical and Health Science, Edith Cowan University, Perth, WA, Australia.
⁴ Cancer and Palliative Care Outcomes Centre, School of Nursing, Faculty of Health, Queensland University of Technology (QUT), Brisbane, QLD, Australia.
⁵ Institute for Health Research, The University of Notre Dame Australia, Perth, WA, Australia.
⁶ Internal Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA.
⁷ Division of General Internal Medicine and Sidney Kimmel Comprehensive Cancer Center, John Hopkins Medical Institutions, Baltimore, MD.
⁸ Centre for Medical Psychology and Evidence-Based Decision-Making, Faculty of Medicine and Health, University of Sydney, Sydney, NSW, Australia.
⁹ School of Graduate Studies, Faculty of Nursing, University of Toronto, Toronto, ON, Canada.
¹⁰ Faculty of Health and Medical Sciences, University of Adelaide, Adelaide, SA, Australia.
¹¹ Northern Adelaide Local Health Network, Adelaide, SA, Australia.
¹² Flinders Health and Medical Research Institute, College of Medicine and Public Health, Flinders University, Adelaide, SA, Australia.
¹³ Flinders Cancer and Innovation Centre, Flinders Medical Centre, Adelaide, SA, Australia.
¹⁴ VieCure, Clinical and Scientific Division, Greenwood Village, CO.
¹⁵ Department of Oncology, University of Calgary, Calgary, ON, Canada.
¹⁶ Department of Medicine, School of Medicine, Yale University, New Haven, CT.
¹⁷ Medical Oncology Division, Yale Cancer Centre, New Haven, CT.
¹⁸ Office of Cancer Survivorship, Division of Cancer Control and Population Sciences, National Cancer Institute, Bethesda, MD.
¹⁹ The Daffodil Centre and University of Sydney: a joint venture with Cancer Council NSW, Sydney, NSW, Australia.
²⁰ Australian Cancer Survivorship Centre, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.
²¹ Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, VIC, Australia.
²² Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY.
²³ Michiana Hematology-Oncology, Mishawaka, IN.
²⁴ Cincinnati Cancer Advisors, Norwood, OH.
²⁵ IMPACCT Research Centre, Faculty of Health, University of Technology Sydney (UTS), Sydney, NSW, Australia.

PMID: 38684036
DOI: 10.1200/OP.23.00716

Abstract

Purpose: People with advanced or metastatic cancer and their caregivers may have different care goals and face unique challenges compared with those with early-stage disease or those nearing the end of life. These Multinational Association for Supportive Care in Cancer (MASCC)-ASCO standards and practice recommendations seek to establish consistent provision of quality survivorship care for people affected by advanced or metastatic cancer.

Methods: A MASCC-ASCO expert panel was formed. Standards and recommendations relevant to the provision of quality survivorship care for people affected by advanced or metastatic cancer were developed through conducting (1) a systematic review of unmet supportive care needs; (2) a scoping review of cancer survivorship, supportive care, and palliative care frameworks and guidelines; and (3) an international modified Delphi consensus process.

Results: A systematic review involving 81 studies and a scoping review of 17 guidelines and frameworks informed the initial standards and recommendations. Subsequently, 77 experts (including eight people with lived experience) across 33 countries (33% were low- to middle-resource countries) participated in the Delphi study and achieved ≥94.8% agreement for seven standards, (1) Person-Centered Care; (2) Coordinated and Integrated Care; (3) Evidence-Based and Comprehensive Care; (4) Evaluated and Communicated Care; (5) Accessible and Equitable Care; (6) Sustainable and Resourced Care; and (7) Research and Data-Driven Care, and ≥84.2% agreement across 45 practice recommendations.

Conclusion: Standards of survivorship care for people affected by advanced or metastatic cancer are provided. These MASCC-ASCO standards support optimization of health outcomes and care experiences by providing guidance to stakeholders (health care professionals, leaders, and administrators; governments and health ministries; policymakers; advocacy agencies; cancer survivors and caregivers). Practice recommendations may be used to facilitate future research, practice, policy, and advocacy efforts.Additional information is available at www.mascc.org, www.asco.org/standards and www.asco.org/survivorship-guidelines.